Showing results 1 to 2 of 2
Anti–4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 Blockade Jeon, Seung Hyuck; You, Gihoon; Park, Junsik; Chung, Youseung; Park, Kyungjin; Kim, Hyunjoo; Jeon, Jaehyoung; et al, Clinical Cancer Research, pp.OF1 - OF12, 2024-06 |
Novel anti-4-1BBxPD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade Jeong, Seongju; Park, Eunyoung; Kim, Hyung-Don; Sung, Eunsil; Kim, Hyunjoo; Jeon, Jaehyoung; Kim, Youngkwang; et al, JOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, no.7, 2021 |
Discover